{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:47:27Z","timestamp":1790970447082,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,1,25]],"date-time":"2003-01-25T00:00:00Z","timestamp":1043452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1007\/s00784-002-0187-y","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T22:45:28Z","timestamp":1576104328000},"page":"52-55","source":"Crossref","is-referenced-by-count":66,"title":["Treatment of recurrent temporomandibular joint dislocation with intramuscular botulinum toxin injection"],"prefix":"10.1007","volume":"7","author":[{"given":"Christoph M.","family":"Ziegler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Haag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"M\u00fchling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,1,25]]},"reference":[{"key":"0187_CR1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.46.1.26","volume":"46","author":"Borodic","year":"1996","unstructured":"Borodic G, Johnson E, Goodnough M, Schantz E (1996) Botulinum toxin therapy, immunologic resistance, and problems with available materials. Neurology 46: 26\u201329","journal-title":"Neurology"},{"key":"0187_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1054\/jpai.2002.27142","volume":"3","author":"Borodic","year":"2002","unstructured":"Borodic GE, Acquardo MA (2002) The use of botulinum toxin for the treatment of chronic facial pain. J Pain 3: 21\u201327","journal-title":"J Pain"},{"key":"0187_CR3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0901-5027(97)80014-8","volume":"26","author":"Daelen","year":"1997","unstructured":"Daelen B, Thorwirth V, Koch A (1997) Treatment of recurrent dislocation of the temporomandibular joint with type A botulinum toxin. Int J Oral Maxillofac Surg 26: 458\u2013460","journal-title":"Int J Oral Maxillofac Surg"},{"key":"0187_CR4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/PL00014457","volume":"2","author":"Daelen","year":"1998","unstructured":"Daelen B, Koch A, Thorwirth V (1998) Botulinumtoxinbehandlung der neurogenen Kiefergelenkluxation. Mund Kiefer GesichtsChir 2: 125\u2013129","journal-title":"Mund Kiefer GesichtsChir"},{"key":"0187_CR5","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0278-2391(99)90007-1","volume":"57","author":"Freund","year":"1999","unstructured":"Freund B, Schwartz M, Symington IM (1999) The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings. J Oral Maxillofac Surg 57: 916\u2013921","journal-title":"J Oral Maxillofac Surg"},{"key":"0187_CR6","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1054\/bjom.1999.0238","volume":"38","author":"Freund","year":"2000","unstructured":"Freund B, Schwartz M, Symington JM (2000) Botulinum toxin: new treatment for temporomandibular disorders. Br J Oral Maxillofac Surg 38: 466\u2013471","journal-title":"Br J Oral Maxillofac Surg"},{"key":"0187_CR7","first-page":"127","volume":"23","author":"Holmlund","year":"1999","unstructured":"Holmlund AB, Gynther GW, Kardel R, Axelsson SE (1999) Surgical treatment of temporomandibular joint luxation. Swed Dent J 23: 127\u2013132","journal-title":"Swed Dent J"},{"key":"0187_CR8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/sj.bdj.4809523","volume":"183","author":"Moore","year":"1997","unstructured":"Moore AP, Wood GD (1997) Medical treatment of recurrent temporomandibular joint dislocation using botulinum toxin A. Br Dent J 183: 415\u2013417","journal-title":"Br Dent J"},{"key":"0187_CR9","unstructured":"Naumann M, Hefter H, Heinen F (1999) Dysport. Klinische Anwendung von Botulinumtoxin. Uni-Med, Bremen"},{"key":"0187_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0304-3959(99)00264-X","volume":"85","author":"Porta","year":"2000","unstructured":"Porta M (2000) A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 85: 101\u2013105","journal-title":"Pain"},{"key":"0187_CR11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/PL00014456","volume":"2","author":"Roser","year":"1988","unstructured":"Roser M, Cornelius CP, Topka H (1988) Neuerungen in der MKG-Chirurgie. Lokale Injektionsbehandlung mit Botulinumtoxin A. Mund Kiefer Gesichtschir 2: 121\u2013124","journal-title":"Mund Kiefer Gesichtschir"},{"key":"0187_CR12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s10006-002-0390-7","volume":"6","author":"Umstadt","year":"2002","unstructured":"Umstadt HE (2002) Botulinum toxin in craniomaxillofacial surgery. Mund Kiefer GesichtsChir 6: 236\u2013240","journal-title":"Mund Kiefer GesichtsChir"},{"key":"0187_CR13","first-page":"26","volume":"55","author":"JJ Von Lindern","year":"2000","unstructured":"Von Lindern JJ, Niederhagen B, Berg\u00e9 S, Appel T, Reich RH (2000) Die Behandlung der muskul\u00e4ren Hyperaktivit\u00e4t der Kaumuskulatur mit Botulinumtoxin Typ A. Dtsch Zahn\u00e4rztl Z 55: 26\u201329","journal-title":"Dtsch Zahn\u00e4rztl Z"},{"key":"0187_CR14","first-page":"39","volume":"101","author":"Von","year":"2001","unstructured":"Von Lindern JJ (2001) Type A botulinum toxin in the treatment of chronic facial pain associated with temporo-mandibular dysfunction. Acta Neurol Belg 101: 39\u201341","journal-title":"Acta Neurol Belg"},{"key":"0187_CR15","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1212\/WNL.43.9.1715","volume":"43","author":"Zuber","year":"1993","unstructured":"Zuber M, Sebald M, Bathien N, de Recondo J, Rondot P (1993) Botulinum antibodies in dystonic patients treated with type A botulinum toxin. Frequency and significance. Neurology 43: 1715\u20131718","journal-title":"Neurology"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-002-0187-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-002-0187-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-002-0187-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T22:45:32Z","timestamp":1576104332000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-002-0187-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1,25]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["0187"],"URL":"https:\/\/doi.org\/10.1007\/s00784-002-0187-y","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1,25]]}}}